What’s behind the push to make peptide therapies more readily available

Federal regulators are considering allowing compounding pharmacies to manufacture several peptides that are currently popular among consumers.

Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to meet demand.

(Image credit: George Frey/Bloomberg)

Source Author
Author: Source Author

Source: NPR.

Written by

Will Stone

in

More posts